The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConvaTec Regulatory News (CTEC)

Share Price Information for ConvaTec (CTEC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 257.80
Bid: 257.20
Ask: 257.60
Change: -17.80 (-6.46%)
Spread: 0.40 (0.156%)
Open: 267.80
High: 268.40
Low: 255.80
Prev. Close: 275.60
CTEC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Corrected Poll Result

11 May 2018 15:27

RNS Number : 8674N
ConvaTec Group PLC
11 May 2018
 

 

Result of Meeting

 

 

CONVATEC GROUP PLC - AGM

11 MAY 2018 - CORRECTED POLL RESULT

 

ConvaTec Group Plc ("ConvaTec"), a leading global medical products and technologies company, held its annual general meeting today. The results of the poll held in relation to the resolutions proposed at the meeting are set out below. The number of votes withheld has been corrected and a column of number of votes cast included.

 

 

For (see note 2)

Against (see note 2)

Number of votes withheld (see note 3)

Number of votes cast

Total Capital Instructed

Resolution

No of shares

%

No of Shares

%

 

1

Receive Annual Report and Accounts

1,490,995,091

100.00

2,052

0.00

429,366

 

1,490,997,143

76.39%

2

Approve the Directors' Remuneration Report

1,457,090,861

98.33

24,766,857

1.67

 

9,568,789

 

1,481,857,718

75.92%

3

Declare Final Dividend

1,490,997,143

100.00

0

0.00

429,366

 

1,490,997,143

76.39%

4

Re-elect Sir Christopher Gent as a Director

1,483,108,674

99.47

7,885,399

0.53

432,436

 

1,490,994,073

76.39%

5

Re-elect Paul Moraviec as a Director

1,488,939,928

99.86

2,054,145

0.14

432,436

 

1,490,994,073

76.39%

6

Elect Frank Schulkes as a Director

1,481,688,827

99.38

9,305,246

0.62

 

432,436

 

1,490,994,073

76.39%

7

Re-elect Steve Holliday as a Director

1,482,717,535

99.44

8,277,540

0.56

431,434

 

1,490,995,075

76.39%

8

Re-elect Jesper Ovesen as a Director

1,476,891,196

99.05

14,102,877

0.95

432,436

 

1,490,994,073

76.39%

9

Re-elect Rick Anderson as a Director

1,488,985,560

99.87

2,009,487

0.13

 

431,462

 

1,490,995,047

76.39%

10

Re-elect Kasim Kutay as a Director

1,488,564,111

99.84

2,429,436

0.16

 

432,962

 

1,490,993,547

76.39%

11

Elect Ros Rivaz as a Director

1,486,522,754

99.70

4,471,319

0.30

 

432,436

 

1,490,994,073

76.39%

12

Elect Regina Benjamin as a Director

1,488,488,383

99.83

2,506,166

0.17

 

431,960

 

1,490,994,549

76.39%

13

Elect Margaret Ewing as a Director

1,488,980,460

99.86

2,014,587

0.14

 

431,462

 

1,490,995,047

76.39%

14

Re-appoint Deloitte LLP as auditors

1,490,989,671

100.00

6,418

0.00

 

430,420

 

1,490,996,089

76.39%

15

Authorise the Directors to agree the auditors' remuneration

1,490,994,110

100.00

3,033

0.00

 

 

429,366

 

 

1,490,997,143

76.39%

16

Authorise allotment of shares

1,479,661,716

99.25

11,131,674

0.75

 

633,119

 

1,490,793,390

76.38%

17

Disapply pre-emption rights*

1,490,781,972

99.99

213,817

0.01

 

430,720

 

1,490,995,789

76.39%

18

Disapply pre-emption rights in connection with an acquisition or specified capital investment*

1,428,938,102

95.84

62,052,586

4.16

 

 

 

435,820

 

 

 

1,490,990,688

76.39%

19

Authorise purchase of own shares*

1,485,284,913

99.75

3,698,352

0.25

 

2,443,243

 

1,488,983,265

76.29%

20

Authorise political donations and political expenditure

1,485,209,550

99.91

1,303,630

0.09

 

 

4,913,329

 

 

1,486,513,180

76.16%

21

Call general meetings on 14 days' notice*

1,442,987,025

97.07

43,526,671

2.93

4,912,813

 

1,486,513,696

76.16%

 

*Special Resolution

 

 

NOTES:

 

1. All resolutions were passed.

2. Votes "For" and "Against" are expressed as a percentage of votes received.

3. A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

4. Total number of shares in issue at 6.30pm on 8 May 2018 was 1,951,850,599 shares. Up to 76.39% of voting capital was instructed.

 

 

 

 

 

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions. The Company is listed on the London Stock Exchange (stock symbol: CTEC) and has leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. www.convatecgroup.com

 

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

Enquiries

 

Analysts and Investors

 

John Crosse, VP Investor Relations +44 (0)7500 141 435

Kirsty Law, Director Investor Relations +44 (0)7470 909 582

investorrelations@convatec.com

 

Media

 

Bobby Leach, VP Group Corporate Affairs +44 (0)7770 842 226

Finsbury +44 (0)207 251 3801 

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

# # #

END

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMSFDFLFFASEEI
Date   Source Headline
3rd Aug 20177:00 amRNSConvaTec Group Plc First Half 2017 Results
1st Aug 201710:31 amRNSHolding(s) in Company
20th Jul 20177:00 amRNSConvaTec Acquisition of Woodbury Holdings
21st Jun 20177:00 amRNSDirectorate Change
16th Jun 20179:20 amRNSChange in External Directorships
13th Jun 20175:05 pmRNSHolding(s) in Company
12th Jun 20174:35 pmRNSHolding(s) in Company
9th Jun 201711:45 amRNSHolding(s) in Company
9th Jun 201711:41 amRNSHolding(s) in Company
9th Jun 20177:00 amRNSAnnouncement on Board of Directors
6th Jun 20177:00 amRNSResult of placing in ConvaTec Group Plc
5th Jun 20174:53 pmRNSProposed Placing in ConvaTec Group Plc
12th May 20177:00 amRNSSpecial Resolutions available at NSM
11th May 20172:22 pmRNSResults of AGM
4th May 20177:00 amRNSQ1 Trading Update ended 31 March 2017
2nd May 20177:00 amRNSLaunch of Flexi-Seal
5th Apr 20177:00 amRNSConvaTec Announces U.S. Launch of Foam Lite
4th Apr 20177:00 amRNSNotice of Annual General Meeting
3rd Apr 20173:00 pmRNSExecutive Committee
31st Mar 20175:22 pmRNSNotification of major interest in shares
31st Mar 20172:07 pmRNSNotification of major interest in shares
31st Mar 20171:49 pmRNSNotification of major interest in shares
30th Mar 20177:00 amRNSConvaTec expands partnership with Medtronic
29th Mar 20179:44 amRNSDirectorate Change
29th Mar 20177:00 amRNSConvaTec Group Plc Result of Placing
28th Mar 20175:54 pmRNSDirectorate Change
28th Mar 20174:55 pmRNSPlacing Launch and Sale Announcement
23rd Mar 20177:00 amRNSConvaTec Launches Sensi-Care®
21st Mar 20177:00 amRNS2016 Annual Report & Accounts
8th Mar 201712:00 pmRNSDirector/PDMR Shareholding
8th Mar 201712:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20177:00 amRNSConvaTec full year 2016 results
27th Feb 20177:00 amRNSConvaTec Launches me+T recovery
22nd Feb 20177:00 amRNSConvaTec announces US GentleCath Glide launch
7th Feb 20177:00 amRNSNotice of Results
26th Jan 20177:00 amRNSLaunch of EsteemT+ Flex Convex 1-piece System
16th Jan 201712:13 pmRNSAppointment of Joint Corporate Brokers
4th Jan 20177:00 amRNSCONVATEC ANNOUNCES ACQUISITION OF EUROTEC
14th Dec 20161:59 pmRNSAnnouncement of margin loan
8th Dec 20161:00 pmRNSAnalyst Presentation
1st Dec 20167:00 amRNSHolding(s) in Company
1st Dec 20167:00 amRNSHolding(s) in Company
1st Dec 20167:00 amRNSHolding(s) in Company
1st Dec 20167:00 amRNSHolding(s) in Company
1st Dec 20167:00 amRNSTotal Voting Rights
15th Nov 20167:00 amRNSDirector/PDMR Shareholding
15th Nov 20167:00 amRNSDirector/PDMR Shareholding
14th Nov 20167:00 amRNSExercise of Over-allotment Option
8th Nov 20164:03 pmRNSNotification of major interest in shares
3rd Nov 20163:25 pmRNSNotification of major interest in shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.